Amanda Mocroft spends much of her time researching Internal medicine, Immunology, Acquired immunodeficiency syndrome, Incidence and Viral load. Amanda Mocroft studies Internal medicine, namely Cohort. Her study in Prospective cohort study extends to Immunology with its themes.
Her Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Epidemiology, Cohort study, Disease, Cause of death and Risk factor. Amanda Mocroft combines subjects such as Non-Hodgkin's lymphoma and Confidence interval with her study of Incidence. Amanda Mocroft has researched Viral load in several fields, including HBsAg, Proportional hazards model and Hazard ratio.
The scientist’s investigation covers issues in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Incidence and Viral load. Her study ties her expertise on Gastroenterology together with the subject of Internal medicine. In her research on the topic of Immunology, Mortality rate is strongly related with Prospective cohort study.
Her Acquired immunodeficiency syndrome research is multidisciplinary, incorporating elements of Pharmacotherapy, Epidemiology, Pediatrics and Disease. Her biological study spans a wide range of topics, including Cancer, Interquartile range, Surgery, Poisson regression and Risk factor. Within one scientific family, Amanda Mocroft focuses on topics pertaining to Regimen under Viral load, and may sometimes address concerns connected to Efavirenz.
Her scientific interests lie mostly in Internal medicine, Cohort, Confidence interval, Cohort study and Poisson regression. Her Internal medicine study frequently links to adjacent areas such as Gastroenterology. The various areas that she examines in her Cohort study include Regimen, Acquired immunodeficiency syndrome, Immunology, Viral load and Hazard ratio.
Her Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Survival analysis and Epidemiology. She focuses mostly in the field of Cohort study, narrowing it down to matters related to Risk factor and, in some cases, Immunodeficiency. Her Incidence research is multidisciplinary, incorporating perspectives in Coinfection and Surgery.
Her main research concerns Internal medicine, Cohort study, Cohort, Confidence interval and Acquired immunodeficiency syndrome. Her work deals with themes such as Surgery and Poisson regression, which intersect with Internal medicine. Amanda Mocroft interconnects Body mass index, Proportional hazards model and Tuberculosis in the investigation of issues within Cohort study.
Her Proportional hazards model research includes themes of Men who have sex with men, Immunology and Virology. Her Epidemiology research extends to the thematically linked field of Acquired immunodeficiency syndrome. Her research in Incidence intersects with topics in Coinfection, Hepatitis C and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Changing patterns of mortality across Europe in patients infected with HIV-1.
A Mocroft;S Vella;TL Benfield;A Chiesi.
The Lancet (1998)
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft;B Ledergerber;C Katlama;O Kirk.
The Lancet (2003)
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
Deborah Konopnicki;Amanda Mocroft;S. De Wit;Francisco Antunes.
AIDS across Europe, 1994–98: the EuroSIDA study
A Mocroft;C Katlama;AM Johnson;C Pradier.
The Lancet (2000)
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study
Esteban Martínez;Amanda Mocroft;Miguel A García-Viejo;José B Pérez-Cuevas.
The Lancet (2001)
Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy
Jiirgen K. Rockstroh;Amanda Mocroft;Vincent Soriano;Cristina Tural.
The Journal of Infectious Diseases (2005)
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
Amanda Mocroft;Ole Kirk;Simon E. Barton;Manfred Dietrich.
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.
Esteban Martinez;José L. Blanco;Juan A. Arnaiz;José B. Perez-Cuevas.
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
Amanda Mocroft;Ole Kirk;Peter Reiss;Stephane De Wit.
Late presentation of HIV infection: a consensus definition
A Antinori;T Coenen;D Costagiola;N Dedes.
Hiv Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: